MedTrace Logo

Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

NCT06796270 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-01-28

No results posted yet for this study

Summary

The purpose of this study was to evaluate the efficacy and safety of large fractionation radiotherapy in nasopharyngeal carcinoma patients, and to analyze whether Hypofractionated radiotherapy is not inferior to conventional radiotherapy.

Conditions

  • Nasopharyngeal Carcinoma (NPC)

Interventions

RADIATION

Hypofractionated radiotherapy

The patients with nasopharyngeal carcinoma were given the dose of large segmentation radiotherapy, 2.64Gy/ time, 5 times/week, a total of 25 times, a total of 66Gy/5 weeks.

Sponsors & Collaborators

  • The Second Affiliated Hospital of Hainan Medical University

    lead OTHER

Principal Investigators

  • yuecan zeng, doctor · The Second Affiliated Hospital of Hainan Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-20
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06796270 on ClinicalTrials.gov